Research progress on the correlation between T cell subsets and prognosis of diffuse large B-cell lymphoma / 中国肿瘤临床

Diffuse large B-cell lymphoma(DLBCL)is the most common type of non-Hodgkin lymphoma,and is characterized by great hetero-geneity.The use of rituximab in treatment regimens has increased the patient survival rate,but some patients experience poor efficacy.It thus remains necessary to find new prognostic indicators to screen high-risk patients and provide targeted treatment.In recent years,many studies have confirmed correlations between T cell subsets and prognosis in DLBCL patients.This article will review the effects of different T cells on the prognosis in DLBCL patients.